Form 4: AdvanSix Controller Christopher Gramm Executes Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Christopher Gramm, Controller of AdvanSix Inc., exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- On October 4, 2024, Christopher Gramm, Controller of AdvanSix Inc., exercised options to purchase 270 shares of AdvanSix common stock at a price of $14.29 per share.
- Simultaneously, Gramm sold 270 shares of AdvanSix common stock at a weighted average price of $32.00.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on March 13, 2024.
- Following these transactions, Gramm directly owns 43,463 shares of AdvanSix common stock and holds options for 4,891 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider trading activity. It doesn't inherently convey positive or negative sentiment about the company's prospects. The transactions are part of a pre-arranged plan, reducing the likelihood of a significant market reaction.
Industry Context
This filing is a routine disclosure of insider transactions. It is common for executives to utilize 10b5-1 plans to manage their stock holdings and avoid accusations of trading on inside information. The filing itself doesn't provide specific insight into AdvanSix's performance or strategy, but it does indicate that a key executive is exercising and selling shares, which could be interpreted in various ways by the market.
Comparison to Industry Standards
- Executive compensation practices, including stock options and 10b5-1 trading plans, are common across publicly traded companies.
- Companies like Honeywell (a former parent of AdvanSix) and other chemical manufacturers often use similar compensation structures to incentivize and retain key personnel.
- The specific details of the plan, such as vesting schedules and exercise prices, would be benchmarked against industry peers to ensure competitiveness.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by an executive.
- The impact is likely to be minimal as the transactions were pre-planned under a 10b5-1 trading plan.
Key Dates
| Date | Description |
|---|---|
| 02/26/2021 | First vesting date of the stock option in one-third increments. |
| 02/26/2022 | Second vesting date of the stock option in one-third increments. |
| 02/26/2023 | Final vesting date of the stock option in one-third increments. |
| 03/13/2024 | Date the reporting person adopted the Rule 10b5-1 trading plan. |
| 10/04/2024 | Date of the transaction (exercise of options and sale of shares). |
| 10/07/2024 | Date of signature on the Form 4 filing. |
| 02/26/2030 | Expiration date of the stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.